Cardiovascular Risk Reduction in Patients With Chronic Kidney Disease Potential for Targeting Inflammation With Canakinumab

被引：12
|
作者：
Cherney, David Z. I. [1 ,2 ]
Lytvyn, Yuliya [1 ,2 ]
McCullough, Peter A. [3 ]
机构：
[1] Toronto Gen Hosp, Div Nephrol, Dept Med, Toronto, ON, Canada
[2] Univ Toronto, Dept Physiol, Toronto, ON, Canada
[3] Baylor Univ, Med Ctr, Baylor Heart & Vasc Hosp, Dallas, TX USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2018年 / 71卷 / 21期
关键词：
canakinumab; cardiovascular risk; CKD; inflammation; C-REACTIVE PROTEIN; INTERLEUKIN-1-BETA INHIBITION;
D O I：
10.1016/j.jacc.2018.04.008
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2415 / 2418
页数：4
相关论文
共 50 条
  • [21] Dyslipidemia in Chronic Kidney Disease: Are Statins Still Indicated in Reduction Cardiovascular Risk in Patients on Dialysis Treatment?
    Scarpioni, Roberto
    Ricardi, Marco
    Melfa, Luigi
    Cristinelli, Luciano
    CARDIOVASCULAR THERAPEUTICS, 2010, 28 (06) : 361 - 368
  • [22] Inflammation as a risk factor and target for therapy in chronic kidney disease
    Miyamoto, Tetsu
    Carrero, Juan J.
    Stenvinkel, Peter
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2011, 20 (06) : 662 - 668
  • [23] Are biomarkers useful for assessing cardiovascular risk in patients with chronic kidney disease?
    Rubin, Clifford
    Nolin, Thomas D.
    Himmelfarb, Jonathan
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2007, 16 (06) : 506 - 511
  • [24] Cardiovascular Risk and Mineral Bone Disorder in Patients with Chronic Kidney Disease
    Staude, Hagen
    Jeske, Susann
    Schmitz, Karin
    Warncke, Gert
    Fischer, Dagmar-Christiane
    KIDNEY & BLOOD PRESSURE RESEARCH, 2013, 37 (01) : 68 - 83
  • [25] Resistin Contribution to Cardiovascular Risk in Chronic Kidney Disease Male Patients
    Romejko, Katarzyna
    Rymarz, Aleksandra
    Szamotulska, Katarzyna
    Bartoszewicz, Zbigniew
    Rozmyslowicz, Tomasz
    Niemczyk, Stanislaw
    CELLS, 2023, 12 (07)
  • [26] CARDIOVASCULAR AND NEPHROLOGICAL RISK IN PATIENTS WITH CHRONIC KIDNEY DISEASE IN AMBULATORY CARE
    Kuryata, O.
    Semenov, V
    MEDICNI PERSPEKTIVI, 2019, 24 (03): : 15 - 21
  • [27] Inflammation in chronic kidney disease: role in the progression of renal and cardiovascular disease
    Douglas M. Silverstein
    Pediatric Nephrology, 2009, 24 : 1445 - 1452
  • [28] The Impact of Insulin Resistance and Chronic Kidney Disease on Inflammation and Cardiovascular Disease
    Kosmas, Constantine E.
    Silverio, Delia
    Tsomidou, Christiana
    Salcedo, Maria D.
    Montan, Peter D.
    Guzman, Eliscer
    CLINICAL MEDICINE INSIGHTS-ENDOCRINOLOGY AND DIABETES, 2018, 11
  • [29] Intima-Media Thickness Is Associated with Inflammation and Traditional Cardiovascular Risk Factors in Non-Dialysis-Dependent Patients with Chronic Kidney Disease
    Lemos, Marcelo M.
    Jancikic, Alessandra D. B.
    Sanches, Fabiana M. R.
    Christofalo, Dejaldo M.
    Ajzen, Sergio A.
    Carvalho, Aluizio B.
    Draibe, Sergio A.
    Canziani, Maria Eugenia F.
    NEPHRON CLINICAL PRACTICE, 2010, 115 (03): : C189 - C194
  • [30] Targeting Inflammation to Reduce Residual Cardiovascular Risk
    Ajala, Oluremi N.
    Everett, Brendan M.
    CURRENT ATHEROSCLEROSIS REPORTS, 2020, 22 (11)
12345